CCM vs MRK
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
CCM exhibits severe financial distress, anchored by a weak Piotroski F-Score of 3/9 and a critical liquidity crisis. The company suffers from negative gross margins (-11.44%), meaning it loses money on every unit of service provided before operating expenses are even considered. With a Price-to-Book ratio of -0.05, the company has negative shareholder equity, and a Quick Ratio of 0.10 indicates an inability to meet short-term obligations. Combined with declining revenue (-8.30% YoY) and a 5-year price collapse of 89%, the fundamental outlook is highly precarious.
MRK shows neutral fundamentals based on deterministic rules. Financial strength is weak (F-Score 3/9). Mixed signals with both opportunities and risks present.
Compare Another Pair
Related Comparisons
CCM vs MRK: Head-to-Head Comparison
This page compares Concord Medical Services Holdings Limited (CCM) and Merck & Co., Inc. (MRK) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.